about
Chromobacterium violaceum: a review of pharmacological and industiral perspectivesViolacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cellsViolacein induces death of resistant leukaemia cells via kinome reprogramming, endoplasmic reticulum stress and Golgi apparatus collapseViolacein Treatment Modulates Acute and Chronic Inflammation through the Suppression of Cytokine Production and Induction of Regulatory T CellsEcological-friendly pigments from fungi.Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor.Effect of Eugenol against Streptococcus agalactiae and Synergistic Interaction with Biologically Produced Silver NanoparticlesIncreased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.Antibacterial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant Staphylococcus aureus (MRSA) strains.Violacein: properties and biological activities.New aspects of nanopharmaceutical delivery systems.The effects of dimensionality on electrochemical sensors based on carbon nanotubes and metallic nanowires.Review of cellulose nanocrystals patents: preparation, composites and general applications.Redox-enzymes, cells and micro-organisms acting on carbon nanostructures transformation: a mini-review.Biogenic nanoparticles: copper, copper oxides, copper sulphides, complex copper nanostructures and their applications.Biogenic synthesis of nanostructured iron compounds: applications and perspectives.Are white-rot fungi a real biotechnological option for the improvement of environmental health?Bioactivity, mechanism of action, and cytotoxicity of copper-based nanoparticles: a review.Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects.Nanotoxicity of graphene and graphene oxide.Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review.Nanodevices for the immobilization of therapeutic enzymes.Fungi as an efficient mycosystem for the synthesis of metal nanoparticles: progress and key aspects of research.Advances in Dental Materials through Nanotechnology: Facts, Perspectives and Toxicological Aspects.Development of double emulsion nanoparticles for the encapsulation of bovine serum albumin.Antimicrobial textiles: Biogenic silver nanoparticles against Candida and Xanthomonas.Antimicrobial activity of biogenic silver nanoparticles, and silver chloride nanoparticles: an overview and comments.Nanoparticulated Nitric Oxide Donors and their Biomedical Applications.Nanopharmaceuticals as a solution to neglected diseases: Is it possible?Quantification of Lactobacillus in fermented milk by multivariate image analysis with least-squares support-vector machines.Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate).Familial tularaemia.Antibacterial Combination of Oleoresin from Copaifera multijuga Hayne and Biogenic Silver Nanoparticles Towards Streptococcus agalactiae.Polymeric Nanoparticles of Enoxaparin as a Delivery System: In Vivo Evaluation in Normal Rats and in a Venous Thrombosis Rat Model.Comparative cytotoxicity of dimethylamide-crotonin in the promyelocytic leukemia cell line (HL60) and human peripheral blood mononuclear cells.Synergistic and Additive Effect of Oregano Essential Oil and Biological Silver Nanoparticles against Multidrug-Resistant Bacterial Strains.Violacein and its beta-cyclodextrin complexes induce apoptosis and differentiation in HL60 cells.Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.Synthesis, antimycobacterial activities and cytotoxicity on V79 of 3-[4'-Y-(1,1'-biphenyl)-4-yl]-N,N-dimethyl-3-(4-X-phenyl)-2-propen-1-amine derivatives.Cytotoxicity of prodigiosin and benznidazole on V79 cells.
P50
Q28155729-6126F2D2-172C-452B-8038-8373216559B6Q28286398-05178F2D-BF0C-453A-9039-1272F3DB606AQ28484370-1E34D90F-C293-4155-BDBB-45E423CB93D9Q28546985-0AF3FB58-0974-4C0B-92C3-E00DA8529E61Q30810612-C8CC8F0A-4F18-40A2-8624-FAABC65C5EC9Q33563394-4644A165-EE5C-44FC-8921-A07569E3F0B3Q35512019-89E8918D-8EDF-477B-81A6-409CDCD9E03EQ36070462-D1BC83BD-291B-4C1C-BC82-CD500629CE7FQ36964585-93F6B4C6-C14E-46B7-A851-A0351F2B6F66Q36967331-B1292E87-CF54-4ADC-892E-7E4CEBF4C5EAQ37197876-B2436286-11CB-4BAD-A84C-56A942E660D0Q37721372-5D74266F-7F43-46EA-847A-3662C869F97BQ37923520-1A682023-8CE7-4F52-AC44-9B187F10C62BQ38066157-72E1AF08-B49B-4271-BDDA-6CFF4EF5BD87Q38108244-AA7D99C1-211C-43B5-BA53-20576632C92FQ38136745-9D7658B2-140D-4149-94B3-BE6512C6D3FFQ38148220-73FC76E2-96CC-4915-8972-DFDB42B0F525Q38168689-7EFF2533-31C1-42CB-A475-25F4A5579298Q38177169-057C3C52-8D6E-4AAE-9C28-40B2F638ECA3Q38178290-3868917E-7093-4CAE-9C71-A8562588B2DFQ38210106-4F6D2711-4782-41EF-92A4-F8EEEEF73045Q38340160-8DD0AB96-EEE5-494C-85ED-3CE9B987B989Q38545443-159D7603-8C83-4F3A-8B14-8E6EC31F1ECEQ38614279-55484740-00E3-4377-A04F-00366FFAB3EEQ38660176-62238B36-CFCC-4808-8C0C-F51F2EBF8479Q38834121-7202ABBF-5E90-493B-8960-47F386E1AE7EQ38862364-6801B811-4618-4BDB-8144-164D6708C9D9Q38925339-197D8C69-0E38-4988-BEDC-A3720AB8F0B7Q39148407-53164D3E-DCC9-4E27-BDF3-D0F65203A190Q39778766-73D467BD-8491-4561-823B-87342D67B1E1Q39913762-1783BA82-4D1E-41A1-9A66-08DE6878CE9DQ40385065-D8088648-508E-4719-BF14-BF1CDA1F851FQ40408509-7B8E54EB-17BA-494A-B377-4E3481EBA42FQ40536845-6170FCA1-A2FB-4BCC-8660-95C27C5FDF73Q40645012-200B4B22-F8BD-441E-8858-0DF23E7A557AQ40652529-63FDE6EE-41DD-47AD-84C3-FE1DDD08FA7FQ40665236-8CE96C9D-FD96-4B15-8741-1DA25EA6F519Q40745391-AB979128-3046-4212-BCB8-F95D6456A0A9Q40764693-E53DF930-8656-4520-9D45-EDBE85B09327Q40853865-48351A8E-D547-4E40-91E5-00E7445DE7DD
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Nelson Durán
@ast
Nelson Durán
@en
Nelson Durán
@es
Nelson Durán
@nl
Nelson Durán
@sl
type
label
Nelson Durán
@ast
Nelson Durán
@en
Nelson Durán
@es
Nelson Durán
@nl
Nelson Durán
@sl
prefLabel
Nelson Durán
@ast
Nelson Durán
@en
Nelson Durán
@es
Nelson Durán
@nl
Nelson Durán
@sl
P214
P227
P244
P106
P1153
23072832700
P21
P213
0000 0004 2514 7471
P214
P227
1046198092
P244
n2011182795
P31
P496
0000-0001-8372-5143
P7859
lccn-n2011182795